Literature DB >> 16402389

Activity profiling of deubiquitinating enzymes in cervical carcinoma biopsies and cell lines.

Ulrika Rolén1, Vera Kobzeva, Natalja Gasparjan, Huib Ovaa, Gösta Winberg, Fjodor Kisseljov, Maria G Masucci.   

Abstract

Ubiquitin specific proteases (USPs) regulate the production and recycling of ubiquitin and are thereby critically involved in the control of cell growth, differentiation, and apoptosis. Increasing evidence implicates deregulation of USPs in malignant transformation but there is very little information on the overall and specific activity of USPs in normal and tumor tissues. We have used a chemistry-based functional proteomics approach to profile the activities of individual USPs in biopsies of human papillomavirus (HPV) carrying cervical carcinoma and adjacent normal tissue. To assess the contribution of HPV proteins, USP activity was also compared in HPV positive and negative cervical carcinoma cell lines and HPV E6/E7 immortalized human keratinocytes. The activity of the C-terminal hydrolases UCH-L3 and UCH37 was upregulated in the majority of tumor tissues compared to the adjacent normal tissues. UCH-L1 activity was lower in a significant proportion of the tumors but to a less extent in advanced tumors. In accordance with the relatively low UCH-L1 activity in tumor biopsies, UCH-L1 was detected only in one out of eight cervical carcinoma lines. UCH-L1, UCH-L3, USP7, and USP9X activity was upregulated following HPV E6/E7 immortalization of keratinocytes, suggesting a role of these enzymes in growth transformation. Copyright 2006 Wiley-Liss, Inc

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16402389     DOI: 10.1002/mc.20177

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  48 in total

1.  Abundance- and Activity-Based Proteomics in Platelet Biology.

Authors:  Stephen P Holly; Xian Chen; Leslie V Parise
Journal:  Curr Proteomics       Date:  2011-10       Impact factor: 0.837

Review 2.  Dissecting the ubiquitin pathway by mass spectrometry.

Authors:  Ping Xu; Junmin Peng
Journal:  Biochim Biophys Acta       Date:  2006-09-14

3.  Method for measuring the activity of deubiquitinating enzymes in cell lines and tissue samples.

Authors:  Percy Griffin; Ashley Sexton; Lauren Macneill; Yoshie Iizuka; Michael K Lee; Martina Bazzaro
Journal:  J Vis Exp       Date:  2015-05-10       Impact factor: 1.355

Review 4.  The Promise of Proteomics in the Study of Oncogenic Viruses.

Authors:  Alison A McBride
Journal:  Mol Cell Proteomics       Date:  2017-01-19       Impact factor: 5.911

5.  Decreased expression of USP9X is associated with poor prognosis in Chinese pancreatic ductal adenocarcinoma patients.

Authors:  Wei Liu; Yanmiao Huo; Jianyu Yang; Xueliang Fu; Minwei Yang; Lingye Tao; Dejun Liu; Junfeng Zhang; Rong Hua; Yongwei Sun
Journal:  Oncol Lett       Date:  2018-04-10       Impact factor: 2.967

6.  High expression of UCH37 is significantly associated with poor prognosis in human epithelial ovarian cancer.

Authors:  Lin Wang; Yan-Jie Chen; Kai Xu; Ya-Yun Wang; Xi-Zhong Shen; Rui-Qin Tu
Journal:  Tumour Biol       Date:  2014-08-15

7.  Context-dependent function of the deubiquitinating enzyme USP9X in pancreatic ductal adenocarcinoma.

Authors:  Jesse L Cox; Phillip J Wilder; Erin L Wuebben; Michel M Ouellette; Michael A Hollingsworth; Angie Rizzino
Journal:  Cancer Biol Ther       Date:  2014-05-19       Impact factor: 4.742

8.  Genomics and proteomics approaches to the study of cancer-stroma interactions.

Authors:  Flávia C Rodrigues-Lisoni; Paulo Peitl; Alessandra Vidotto; Giovana M Polachini; José V Maniglia; Juliana Carmona-Raphe; Bianca R Cunha; Tiago Henrique; Caique F Souza; Rodrigo A P Teixeira; Erica E Fukuyama; Pedro Michaluart; Marcos B de Carvalho; Sonia M Oliani; Eloiza H Tajara; P M Cury; M B de Carvalho; E Dias-Neto; D L A Figueiredo; E E Fukuyama; J F Góis-Filho; A M Leopoldino; R C M Mamede; P Michaluart-Junior; R A Moyses; F G Nóbrega; M P Nóbrega; F D Nunes; E F B Ojopi; L N Serafini; P Severino; A M A Silva; W A Silva; N J F Silveira; S C O M Souza; E H Tajara; V Wünsch-Filho; A Amar; C M Bandeira; M A Braconi; L G Brandão; R M Brandão; A L Canto; M Cerione; R Cicco; M J Chagas; H Chedid; A Costa; B R Cunha; O A Curioni; C S Fortes; S A Franzi; A P Z Frizzera; D Gazito; P E M Guimarães; C M Kaneto; R V M López; R Macarenco; M R Magalhães; C Meneses; A M C Mercante; D G Pinheiro; G M Polachini; A Rapoport; C O Rodini; F C Rodrigues-Lisoni; R V Rodrigues; L Rossi; A R D Santos; M Santos; F Settani; F A M Silva; I T Silva; T B Souza; E Stabenow; J T Takamori; P J Valentim; A Vidotto; F C A Xavier; F Yamagushi; M L Cominato; P M S Correa; G S Mendes; R Paiva; O Ramos; C Silva; M J Silva; M V C Tarlá
Journal:  BMC Med Genomics       Date:  2010-05-04       Impact factor: 3.063

Review 9.  Application of activity-based probes to the study of enzymes involved in cancer progression.

Authors:  Margot G Paulick; Matthew Bogyo
Journal:  Curr Opin Genet Dev       Date:  2008-02-21       Impact factor: 5.578

10.  Expression and functional studies of ubiquitin C-terminal hydrolase L1 regulated genes.

Authors:  Anjali Bheda; Julia Shackelford; Joseph S Pagano
Journal:  PLoS One       Date:  2009-08-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.